US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.700
  • +0.012+1.70%
Close Jan 24 16:00 ET
  • 0.720
  • +0.020+2.86%
Post 19:06 ET
88.32MMarket Cap-0.67P/E (TTM)

Karyopharm Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Dec 31, 2024

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics in the past 3 months

Strong Buy

  • Buy

    83.33%
  • Hold

    16.67%
  • Sell

    0.00%

Price Target

Updated: Dec 31, 2024

The average Karyopharm Therapeutics stock price target is 4.50 with a max estimate of 7.00 and a min estimate of 2.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Trending Stocks

Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.

Unlock Now